Equine Healthcare Market

Equine Healthcare Market (Product Type: Therapeutics and Diagnostics; Indication: Equine Influenza, Equine Herpes virus (EHV), Equine Encephalomyelitis, West Nile Virus, Equine Rabies, Potomac Horse Fever, Osteoarthritis, Tetanus, and Others; and End-user: Veterinary Hospitals, Equine Clinics, Equestrian Facilities, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035

Equine Healthcare Market Outlook 2035

  • The industry was valued at US$ 0.8 Bn in 2024
  • It is estimated to grow at a CAGR of 4.8% from 2025 to 2035 and reach more than US$ 1.3 Bn by the end of 2035

Analyst Viewpoint

Therapeutics such as corticosteroids are being extensively used as joint injections for horses. Bisphosphonates such as tiludronate disodium (Tildren) and clondronate (Osphos) are labeled for controlling clinical signs associated with navicular syndrome. There is a need for research surrounding bisphosphonate’s use in horses under the age of four.

Equine Healthcare Market Revenue Growth

As such, the equine healthcare market is riding on increasing awareness about the importance of horses’ health.

Market Overview

The global equine healthcare market is expected to grow owing to the rise in equine population due to increasing frequency of horse ownership, sports, and recreational activities. Moreover, growing demand for preventive care including vaccinations, deworming, and regular check-ups is expected to foster the overall market growth in the upcoming future. Furthermore, the equine healthcare industry growth is primarily fueled by the rising population of domesticated and sport horses globally. As equestrian sports continue to gain popularity-ranging from horse racing and dressage to endurance and rodeo-there is growing demand for high-quality veterinary care.

Attribute Detail
Equine Healthcare Market Drivers
  • Growing Incidence of Equine Diseases
  • Rising research and development across the veterinary field

Growing Incidence of Equine Diseases Aimed at Improving Consumer Awareness Levels Expected to Drive Equine Healthcare Market Size

The increased prevalence of equine diseases is a key driving force of the equine healthcare market, affecting many segments of the market and leading to rising demand for various products and services. Rising incidence of equine diseases can increase the rate of awareness among horse owners and veterinarians regarding the need for preventive care. This ranges from routine vaccinations, deworming programs, and check-ups.

For example, equine influenza, equine herpesvirus (EHV), and West Nile virus are a few infectious diseases on the rise. Due to this, there is an increasing demand for vaccines against the infections that are potent enough to provide protection to horses against diseases. Likewise, the pressure of internal and external parasites is propelling the demand for effective parasiticides and deworming.

Regular deworming programs are crucial in maintaining the health and functioning of horses and, consequently, increase the market for parasiticides. Disease detection at early stages is an important consideration in equine health care. There is an increase in frequency of more advanced diagnostic tests, such as blood tests, imaging (X-Ray, ultrasound, MRI, and CT scans), and genetic tests.

Health check-ups are more commonly employed by horse owners and veterinarians to keep track of the general health of horses and pick out potential underlying conditions early. Early diagnosis can result in enhanced and less expensive treatment, maximizing long-term horse health and productivity. This is fueling growth in the diagnostic portion of the equine healthcare market.

The rise in incidence of disease is also increasing demand for therapeutic medicine. This comprises a wide range of drugs like antibiotics, anti-inflammatory, and analgesics. Occurrences if diseases like lameness, respiratory disease, and gastrointestinal disease are on the rise, and there is an increasing need for effective medicine. There is also specialized medicine for diseases like equine metabolic syndrome, laminitis, and equine Cushing's.

Increase in Research and Development Activities across the Veterinary Field Anticipated to Bolster Equine Healthcare Market

R&D activities have developed more effective and efficient parasiticides, anti-infectives, and anti-inflammatory chemical species-specific that are less toxic for long-term administration. Slow-release drug and advanced anthelmintics are a few examples, which are more effectively controlling internal parasites with negligible resistance.

Veterinary R&D activities have introduced high-technology imaging and diagnostic modalities like digital radiography, ultrasound, and endoscopy for early diagnosis of musculoskeletal, respiratory, and reproductive disease of horses. The technology enhances treatment efficacy and reduces competition horse downtime. Regenerative medicine–stem cell therapy, platelet-rich plasma (PRP), and prolotherapy technology are revolutionizing equine medicine, particularly joint trauma, tendon/ligament injury, and osteoarthritis care.

The biologic therapies promote healing of performance animals and become increasingly available through research. Genetic diagnosis, biomarker identification, and individualized health planning are being enabled by research and development activities for horses. Accuracy testing is facilitating early disease diagnosis of genetic disease, enhanced breeding results, and lifetime health.

Therapeutics Market Segment is Dominating Global Equine Healthcare Market by Product Type

The therapeutics industry in the equine health sector is controlled by the therapeutics segment due to the prevalence of the major equine diseases and the focal role of drugs in general veterinary practice. The equine animals are prone to numerous forms of diseases like respiratory infections, gastrointestinal disease, arthritic inflammation, and parasitic disease that have to be treated and cured by continuous drug therapy. Therefore, gastrointestinal medications, anti-infectives, and anti-inflammatory drugs are never in short supply, and therapeutics become a routine part of normal equine care.

The most significant aspect of this ubiquity is the rampant use of parasiticides. Deworming is a fundamental part of equine husbandry, especially in breeding and agricultural operations where parasites are managed due to their necessity to be maintained under control for herd well-being. With growing resistance to the traditional deworming medicines, demand for good and safe parasiticides is even higher.

Equine Healthcare Market Share By Product Type 2024

Anti-inflammatories and analgesics are also administered regularly to race-oriented horses to cure lameness and arthritis so that they can recover faster and compete on equal terms. Furthermore, developments in veterinary pharmaceuticals and medicines have augmented the arsenal of treatments.

Targeted therapies, long-acting injectables, and regenerative medications such as stem cell treatment and platelet-rich plasma (PRP) are being consumed in huge volumes, most notably on premium horses such as racehorses and showjumpers. The innovations are introducing efficacy and appeal to therapeutics, thus inducing greater uptake among both - the developed nations and emerging countries.

Regional Outlook for Equine Healthcare Market

Attribute Detail
Leading Region North America

North America, and the United States above all, holds the largest equine healthcare market share due to a series of healthy health policy decisions, high level of awareness, buying power, and common availability. Additionally, North American consumers place high importance on convenience, cleanliness, and technology, and hence the market is open to high-end and innovative products.

Equine Healthcare Market Regional Analysis In 2024

Analysis of Key Players of Equine Healthcare Market

Leading companies are partnering with hospitals, specialty clinics, and research institutes to expand inorganically. Zoetis, Arthrex, Inc., Dechra Pharmaceuticals, Boehringer Ingelheim, Animal Health USA Inc., Ceva, Heska Corporation, Merck & Co., Inc., Esaote SpA, IDEXX, Covetrus, Elanco, Cargill Incorporated, Santa Cruz Biotechnology Inc. are the prominent equine healthcare market players.

Each of these players has been have been profiled in the equine healthcare industry research report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

Key Developments in Equine Healthcare Market

  • In February 2024, Dechra has launched Pergocoat, a new treatment for pituitary pars intermedia dysfunction (PPID), otherwise known as equine Cushing’s disease. Pergocoat contains pergolide as its active ingredient, a potent, long-acting dopamine receptor agonist and is available in both 0.5mg (off-white) and 1mg (yellow) tablets for accurate dosing without the need to split tablets.
  • In June 2024, Vetlen Advanced Veterinary Devices announced the creation of its new device for delivering antibiotic medication directly to infected surgical and wound sites in canine and equine patients is now available. The new drug delivery device-Vetlen Pouch-offers a new method for delivering daily localized, high-dose antibiotic therapy for treating infected wounds in dogs and horses, according to a news release.

Equine Healthcare Market Snapshot

Attribute Detail
Size in 2024 US$ 0.8 Bn
Forecast Value in 2035 US$ 1.3 Bn
CAGR 4.8%
Forecast Period 2025-2035
Historical Data Available for 2020-2023
Quantitative Units US$ Mn for Value
Market Analysis It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, value chain analysis, and key trend analysis.
Competition Landscape
  • Competition Matrix
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials
Format Electronic (PDF) + Excel
Segmentation
  • Product Type
    • Therapeutics
      • Drugs
        • Anti-Infective
        • Anti-inflammatory
        • Parasiticides
        • Others (Hormone and Substitutes, etc.)
      • Vaccine
        • Inactivated
        • Live Attenuated
        • Recombinant
        • Others (DNA vaccine, etc.)
      • Supplemental Feed additives
        • Proteins and amino acids
        • Vitamins
        • Enzymes
        • Minerals
        • Others (Probiotics, etc.)
      • Regenerative Medicine
    • Diagnostics
      • Diagnostic Kits & Reagents
      • Instruments
  • Indication
    • Equine Influenza
    • Equine Herpes virus (EHV)
    • Equine Encephalomyelitis
    • West Nile Virus
    • Equine Rabies
    • Potomac Horse Fever
    • Osteoarthritis
    • Tetanus
    • Others (Equine Infectious Anemia, etc.)
  • End-user
    • Veterinary Hospitals
    • Equine Clinics
    • Equestrian Facilities
    • Others
Regions Covered
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Countries Covered
  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa
Companies Profiled
  • Zoetis
  • Arthrex, Inc.
  • Dechra Pharmaceuticals
  • Boehringer Ingelheim Animal Health USA Inc.
  • Ceva
  • Heska Corporation
  • Merck & Co., Inc.,
  • Esaote SpA
  • IDEXX
  • Covetrus
  • Elanco
  • Cargill, Incorporated
  • Santa Cruz Biotechnology Inc.
  • Other Prominent Players
Customization Scope Available upon request
Pricing Available upon request

Frequently Asked Questions

How big was the global Equine Healthcare Market in 2024?

The global equine healthcare market was valued at US$ 0.8 Bn in 2024.

How big will the global equine healthcare business be in 2035?

Equine Healthcare business is projected to cross US$ 1.3 Bn by the end of 2035.

What are the key factors driving the demand for equine healthcare?

Growing incidence of equine diseases and rising research and development across the veterinary field.

What will be the CAGR of the equine healthcare industry during the forecast period?

The CAGR is anticipated to be 4.8% from 2025 to 2035.

Which region will account for a major share of the equine healthcare market during the forecast period?

North America is expected to account for the largest share from 2025 to 2035.

Who are the prominent equine healthcare providers?

Zoetis, Arthrex, Inc., Dechra Pharmaceuticals, Boehringer Ingelheim, Animal Health USA Inc., Ceva, Heska Corporation, Merck & Co., Inc., Esaote SpA, IDEXX, Covetrus, Elanco, Cargill Incorporated, Santa Cruz Biotechnology Inc, and other players are the prominent Equine Healthcare Market players.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Equine Healthcare Market

4. Market Overview

    4.1. Introduction

        4.1.1. Segment Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Equine Healthcare Market Analysis and Forecasts, 2020 to 2035

        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

    5.1. Equine Healthcare Market Trends

    5.2. Regulatory Scenario Across Key Regions/Countries

    5.3. PESTEL Analysis

    5.4. PORTER's Analysis

    5.5. Pipeline Analysis for Equine Drugs and Vaccines

    5.6. Pricing Trends of Equine Health Care Products

    5.7. Key Industry Events

    5.8. Epidemiology Analysis Across Key Regions/Countries

    5.9. Go-to-Market Strategy for New Market Entrants

    5.10. Key Shortlisting Metrics for End-users

    5.11. Benchmarking of the Products Offered by the Leading Competitors

6. Global Equine Healthcare Market Analysis and Forecasts, By Product Type

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast By Product Type, 2020 to 2035

        6.3.1. Therapeutics

            6.3.1.1. Drugs

                6.3.1.1.1. Anti-Infective

                6.3.1.1.2. Anti-inflammatory

                6.3.1.1.3. Parasiticides

                6.3.1.1.4. Others

            6.3.1.2. Vaccine

                6.3.1.2.1. Inactivated

                6.3.1.2.2. Live Attenuated

                6.3.1.2.3. Recombinant

                6.3.1.2.4. Others

            6.3.1.3. Supplemental Feed additives

                6.3.1.3.1. Proteins and amino acids

                6.3.1.3.2. Vitamins

                6.3.1.3.3. Enzymes

                6.3.1.3.4. Minerals

                6.3.1.3.5. Others

            6.3.1.4. Regenerative Medicine

        6.3.2. Diagnostics

            6.3.2.1. Diagnostic Kits & Reagents

            6.3.2.2. Instruments

    6.4. Market Attractiveness By Product Type

7. Global Equine Healthcare Market Analysis and Forecasts, By Indication

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast By Indication, 2020 to 2035

        7.3.1. Equine Influenza

        7.3.2. Equine Herpes virus (EHV)

        7.3.3. Equine Encephalomyelitis

        7.3.4. West Nile Virus

        7.3.5. Equine Rabies

        7.3.6. Potomac Horse Fever

        7.3.7. Osteoarthritis

        7.3.8. Tetanus

        7.3.9. Others

    7.4. Market Attractiveness By Indication

8. Global Equine Healthcare Market Analysis and Forecasts, By End-user

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Market Value Forecast By End-user, 2020 to 2035

        8.3.1. Veterinary Hospitals

        8.3.2. Equine Clinics

        8.3.3. Equestrian Facilities

        8.3.4. Others

    8.4. Market Attractiveness By End-user

9. Global Equine Healthcare Market Analysis and Forecasts, By Region

    9.1. Key Findings

    9.2. Market Value Forecast By Region

        9.2.1. North America

        9.2.2. Europe

        9.2.3. Asia Pacific

        9.2.4. Latin America

        9.2.5. Middle East & Africa

    9.3. Market Attractiveness By Country/Region

10. North America Equine Healthcare Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value Forecast By Product Type, 2020 to 2035

        10.2.1. Therapeutics

            10.2.1.1. Drugs

                10.2.1.1.1. Anti-Infective

                10.2.1.1.2. Anti-inflammatory

                10.2.1.1.3. Parasiticides

                10.2.1.1.4. Others

            10.2.1.2. Vaccine

                10.2.1.2.1. Inactivated

                10.2.1.2.2. Live Attenuated

                10.2.1.2.3. Recombinant

                10.2.1.2.4. Others

            10.2.1.3. Supplemental Feed additives

                10.2.1.3.1. Proteins and amino acids

                10.2.1.3.2. Vitamins

                10.2.1.3.3. Enzymes

                10.2.1.3.4. Minerals

                10.2.1.3.5. Others

            10.2.1.4. Regenerative Medicine

        10.2.2. Diagnostics

            10.2.2.1. Diagnostic Kits & Reagents

            10.2.2.2. Instruments

    10.3. Market Value Forecast By Indication, 2020 to 2035

        10.3.1. Equine Influenza

        10.3.2. Equine Herpes virus (EHV)

        10.3.3. Equine Encephalomyelitis

        10.3.4. West Nile Virus

        10.3.5. Equine Rabies

        10.3.6. Potomac Horse Fever

        10.3.7. Osteoarthritis

        10.3.8. Tetanus

        10.3.9. Others

    10.4. Market Value Forecast By End-user, 2020 to 2035

        10.4.1. Veterinary Hospitals

        10.4.2. Equine Clinics

        10.4.3. Equestrian Facilities

        10.4.4. Others

    10.5. Market Value Forecast By Country, 2020 to 2035

        10.5.1. U.S.

        10.5.2. Canada

    10.6. Market Attractiveness Analysis

        10.6.1. By Product Type

        10.6.2. By Indication

        10.6.3. By End-user

        10.6.4. By Country

11. Europe Equine Healthcare Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast By Product Type, 2020 to 2035

        11.2.1. Therapeutics

            11.2.1.1. Drugs

                11.2.1.1.1. Anti-Infective

                11.2.1.1.2. Anti-inflammatory

                11.2.1.1.3. Parasiticides

                11.2.1.1.4. Others

            11.2.1.2. Vaccine

                11.2.1.2.1. Inactivated

                11.2.1.2.2. Live Attenuated

                11.2.1.2.3. Recombinant

                11.2.1.2.4. Others

            11.2.1.3. Supplemental Feed additives

                11.2.1.3.1. Proteins and amino acids

                11.2.1.3.2. Vitamins

                11.2.1.3.3. Enzymes

                11.2.1.3.4. Minerals

                11.2.1.3.5. Others

            11.2.1.4. Regenerative Medicine

        11.2.2. Diagnostics

            11.2.2.1. Diagnostic Kits & Reagents

            11.2.2.2. Instruments

    11.3. Market Value Forecast By Indication, 2020 to 2035

        11.3.1. Equine Influenza

        11.3.2. Equine Herpes virus (EHV)

        11.3.3. Equine Encephalomyelitis

        11.3.4. West Nile Virus

        11.3.5. Equine Rabies

        11.3.6. Potomac Horse Fever

        11.3.7. Osteoarthritis

        11.3.8. Tetanus

        11.3.9. Others

    11.4. Market Value Forecast By End-user, 2020 to 2035

        11.4.1. Veterinary Hospitals

        11.4.2. Equine Clinics

        11.4.3. Equestrian Facilities

        11.4.4. Others

    11.5. Market Value Forecast By Country/Sub-region, 2020 to 2035

        11.5.1. Germany

        11.5.2. U.K.

        11.5.3. France

        11.5.4. Italy

        11.5.5. Spain

        11.5.6. Switzerland

        11.5.7. The Netherlands

        11.5.8. Rest of Europe

    11.6. Market Attractiveness Analysis

        11.6.1. By Product Type

        11.6.2. By Indication

        11.6.3. By End-user

        11.6.4. By Country/Sub-region

12. Asia Pacific Equine Healthcare Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast By Product Type, 2020 to 2035

        12.2.1. Therapeutics

            12.2.1.1. Drugs

                12.2.1.1.1. Anti-Infective

                12.2.1.1.2. Anti-inflammatory

                12.2.1.1.3. Parasiticides

                12.2.1.1.4. Others

            12.2.1.2. Vaccine

                12.2.1.2.1. Inactivated

                12.2.1.2.2. Live Attenuated

                12.2.1.2.3. Recombinant

                12.2.1.2.4. Others

            12.2.1.3. Supplemental Feed additives

                12.2.1.3.1. Proteins and amino acids

                12.2.1.3.2. Vitamins

                12.2.1.3.3. Enzymes

                12.2.1.3.4. Minerals

                12.2.1.3.5. Others

            12.2.1.4. Regenerative Medicine

        12.2.2. Diagnostics

            12.2.2.1. Diagnostic Kits & Reagents

            12.2.2.2. Instruments

    12.3. Market Value Forecast By Indication, 2020 to 2035

        12.3.1. Equine Influenza

        12.3.2. Equine Herpes virus (EHV)

        12.3.3. Equine Encephalomyelitis

        12.3.4. West Nile Virus

        12.3.5. Equine Rabies

        12.3.6. Potomac Horse Fever

        12.3.7. Osteoarthritis

        12.3.8. Tetanus

        12.3.9. Others

    12.4. Market Value Forecast By End-user, 2020 to 2035

        12.4.1. Veterinary Hospitals

        12.4.2. Equine Clinics

        12.4.3. Equestrian Facilities

        12.4.4. Others

    12.5. Market Value Forecast By Country/Sub-region, 2020 to 2035

        12.5.1. China

        12.5.2. India

        12.5.3. Japan

        12.5.4. South Korea

        12.5.5. Australia & New Zealand

        12.5.6. Rest of Asia Pacific

    12.6. Market Attractiveness Analysis

        12.6.1. By Product Type

        12.6.2. By Indication

        12.6.3. By End-user

        12.6.4. By Country/Sub-region

13. Latin America Equine Healthcare Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast By Product Type, 2020 to 2035

        13.2.1. Therapeutics

            13.2.1.1. Drugs

                13.2.1.1.1. Anti-Infective

                13.2.1.1.2. Anti-inflammatory

                13.2.1.1.3. Parasiticides

                13.2.1.1.4. Others

            13.2.1.2. Vaccine

                13.2.1.2.1. Inactivated

                13.2.1.2.2. Live Attenuated

                13.2.1.2.3. Recombinant

                13.2.1.2.4. Others

            13.2.1.3. Supplemental Feed additives

                13.2.1.3.1. Proteins and amino acids

                13.2.1.3.2. Vitamins

                13.2.1.3.3. Enzymes

                13.2.1.3.4. Minerals

                13.2.1.3.5. Others

            13.2.1.4. Regenerative Medicine

        13.2.2. Diagnostics

            13.2.2.1. Diagnostic Kits & Reagents

            13.2.2.2. Instruments

    13.3. Market Value Forecast By Indication, 2020 to 2035

        13.3.1. Equine Influenza

        13.3.2. Equine Herpes virus (EHV)

        13.3.3. Equine Encephalomyelitis

        13.3.4. West Nile Virus

        13.3.5. Equine Rabies

        13.3.6. Potomac Horse Fever

        13.3.7. Osteoarthritis

        13.3.8. Tetanus

        13.3.9. Others

    13.4. Market Value Forecast By End-user, 2020 to 2035

        13.4.1. Veterinary Hospitals

        13.4.2. Equine Clinics

        13.4.3. Equestrian Facilities

        13.4.4. Others

    13.5. Market Value Forecast By Country/Sub-region, 2020 to 2035

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Argentina

        13.5.4. Rest of Latin America

    13.6. Market Attractiveness Analysis

        13.6.1. By Product Type

        13.6.2. By Indication

        13.6.3. By End-user

        13.6.4. By Country/Sub-region

14. Middle East & Africa Equine Healthcare Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Market Value Forecast By Product Type, 2020 to 2035

        14.2.1. Therapeutics

            14.2.1.1. Drugs

                14.2.1.1.1. Anti-Infective

                14.2.1.1.2. Anti-inflammatory

                14.2.1.1.3. Parasiticides

                14.2.1.1.4. Others

            14.2.1.2. Vaccine

                14.2.1.2.1. Inactivated

                14.2.1.2.2. Live Attenuated

                14.2.1.2.3. Recombinant

                14.2.1.2.4. Others

            14.2.1.3. Supplemental Feed additives

                14.2.1.3.1. Proteins and amino acids

                14.2.1.3.2. Vitamins

                14.2.1.3.3. Enzymes

                14.2.1.3.4. Minerals

                14.2.1.3.5. Others

            14.2.1.4. Regenerative Medicine

        14.2.2. Diagnostics

            14.2.2.1. Diagnostic Kits & Reagents

            14.2.2.2. Instruments

    14.3. Market Value Forecast By Indication, 2020 to 2035

        14.3.1. Equine Influenza

        14.3.2. Equine Herpes virus (EHV)

        14.3.3. Equine Encephalomyelitis

        14.3.4. West Nile Virus

        14.3.5. Equine Rabies

        14.3.6. Potomac Horse Fever

        14.3.7. Osteoarthritis

        14.3.8. Tetanus

        14.3.9. Others

    14.4. Market Value Forecast By End-user, 2020 to 2035

        14.4.1. Veterinary Hospitals

        14.4.2. Equine Clinics

        14.4.3. Equestrian Facilities

        14.4.4. Others

    14.5. Market Value Forecast By Country/Sub-region, 2020 to 2035

        14.5.1. GCC Countries

        14.5.2. South Africa

        14.5.3. Rest of Middle East & Africa

    14.6. Market Attractiveness Analysis

        14.6.1. By Product Type

        14.6.2. By Indication

        14.6.3. By End-user

        14.6.4. By Country/Sub-region

15. Competition Landscape

    15.1. Market Player – Competition Matrix (By Tier and Size of companies)

    15.2. Market Share Analysis By Company (2024)

    15.3. Company Profiles

        15.3.1. Zoetis

            15.3.1.1. Company Overview

            15.3.1.2. Financial Overview

            15.3.1.3. Financial Overview

            15.3.1.4. Business Strategies

            15.3.1.5. Recent Developments

        15.3.2. Arthrex, Inc.

            15.3.2.1. Company Overview

            15.3.2.2. Financial Overview

            15.3.2.3. Financial Overview

            15.3.2.4. Business Strategies

            15.3.2.5. Recent Developments

        15.3.3. Dechra Pharmaceuticals

            15.3.3.1. Company Overview

            15.3.3.2. Financial Overview

            15.3.3.3. Financial Overview

            15.3.3.4. Business Strategies

            15.3.3.5. Recent Developments

        15.3.4. Boehringer Ingelheim Animal Health USA Inc.

            15.3.4.1. Company Overview

            15.3.4.2. Financial Overview

            15.3.4.3. Financial Overview

            15.3.4.4. Business Strategies

            15.3.4.5. Recent Developments

        15.3.5. Ceva

            15.3.5.1. Company Overview

            15.3.5.2. Financial Overview

            15.3.5.3. Financial Overview

            15.3.5.4. Business Strategies

            15.3.5.5. Recent Developments

        15.3.6. Heska Corporation

            15.3.6.1. Company Overview

            15.3.6.2. Financial Overview

            15.3.6.3. Financial Overview

            15.3.6.4. Business Strategies

            15.3.6.5. Recent Developments

        15.3.7. Merck & Co., Inc.,

            15.3.7.1. Company Overview

            15.3.7.2. Financial Overview

            15.3.7.3. Financial Overview

            15.3.7.4. Business Strategies

            15.3.7.5. Recent Developments

        15.3.8. Esaote SpA

            15.3.8.1. Company Overview

            15.3.8.2. Financial Overview

            15.3.8.3. Financial Overview

            15.3.8.4. Business Strategies

            15.3.8.5. Recent Developments

        15.3.9. IDEXX

            15.3.9.1. Company Overview

            15.3.9.2. Financial Overview

            15.3.9.3. Financial Overview

            15.3.9.4. Business Strategies

            15.3.9.5. Recent Developments

        15.3.10. Covetrus

            15.3.10.1. Company Overview

            15.3.10.2. Financial Overview

            15.3.10.3. Financial Overview

            15.3.10.4. Business Strategies

            15.3.10.5. Recent Developments

        15.3.11. Elanco

            15.3.11.1. Company Overview

            15.3.11.2. Financial Overview

            15.3.11.3. Financial Overview

            15.3.11.4. Business Strategies

            15.3.11.5. Recent Developments

        15.3.12. Cargill, Incorporated

            15.3.12.1. Company Overview

            15.3.12.2. Financial Overview

            15.3.12.3. Financial Overview

            15.3.12.4. Business Strategies

            15.3.12.5. Recent Developments

        15.3.13. Santa Cruz Biotechnology Inc.

            15.3.13.1. Company Overview

            15.3.13.2. Financial Overview

            15.3.13.3. Financial Overview

            15.3.13.4. Business Strategies

            15.3.13.5. Recent Developments

        15.3.14. Other Prominent Players

            15.3.14.1. Company Overview

            15.3.14.2. Financial Overview

            15.3.14.3. Financial Overview

            15.3.14.4. Business Strategies

            15.3.14.5. Recent Developments

List of Tables

Table 01: Global Equine Healthcare Market Value (US$ Mn) Forecast, By Product Type, 2020 to 2035

Table 02: Global Equine Healthcare Market Value (US$ Mn) Forecast, By Therapeutics, 2020 to 2035

Table 03: Global Equine Healthcare Market Value (US$ Mn) Forecast, By Drugs, 2020 to 2035

Table 04: Global Equine Healthcare Market Value (US$ Mn) Forecast, By Vaccine, 2020 to 2035

Table 05: Global Equine Healthcare Market Value (US$ Mn) Forecast, By Supplemental Feed Additives, 2020 to 2035

Table 06: Global Equine Healthcare Market Value (US$ Mn) Forecast, By Diagnostics, 2020 to 2035

Table 07: Global Equine Healthcare Market Value (US$ Mn) Forecast, By Indication, 2020 to 2035

Table 08: Global Equine Healthcare Market Value (US$ Mn) Forecast, By End-user, 2020 to 2035

Table 09: Global Equine Healthcare Market Value (US$ Mn) Forecast, By Region, 2020 to 2035

Table 10: North America - Equine Healthcare Market Value (US$ Mn) Forecast, by Country, 2020 to 2035

Table 11: North America - Equine Healthcare Market Value (US$ Mn) Forecast, by Product Type, 2020 to 2035

Table 12: North America - Equine Healthcare Market Value (US$ Mn) Forecast, By Therapeutics, 2020 to 2035

Table 13: North America - Equine Healthcare Market Value (US$ Mn) Forecast, By Drugs, 2020 to 2035

Table 14: North America - Equine Healthcare Market Value (US$ Mn) Forecast, By Vaccine, 2020 to 2035

Table 15: North America - Equine Healthcare Market Value (US$ Mn) Forecast, By Supplemental Feed Additives, 2020 to 2035

Table 16: North America - Equine Healthcare Market Value (US$ Mn) Forecast, By Diagnostics, 2020 to 2035

Table 17: North America - Equine Healthcare Market Value (US$ Mn) Forecast, by Indication, 2020 to 2035

Table 18: North America - Equine Healthcare Market Value (US$ Mn) Forecast, By End-user, 2020 to 2035

Table 19: Europe - Equine Healthcare Market Value (US$ Mn) Forecast, by Country, 2020 to 2035

Table 20: Europe - Equine Healthcare Market Value (US$ Mn) Forecast, by Product Type, 2020 to 2035

Table 21: Europe - Equine Healthcare Market Value (US$ Mn) Forecast, By Therapeutics, 2020 to 2035

Table 22: Europe - Equine Healthcare Market Value (US$ Mn) Forecast, By Drugs, 2020 to 2035

Table 23: Europe - Equine Healthcare Market Value (US$ Mn) Forecast, By Vaccine, 2020 to 2035

Table 24: Europe - Equine Healthcare Market Value (US$ Mn) Forecast, By Supplemental Feed Additives, 2020 to 2035

Table 25: Europe - Equine Healthcare Market Value (US$ Mn) Forecast, By Diagnostics, 2020 to 2035

Table 26: Europe - Equine Healthcare Market Value (US$ Mn) Forecast, by Indication, 2020 to 2035

Table 27: Europe - Equine Healthcare Market Value (US$ Mn) Forecast, By End-user, 2020 to 2035

Table 28: Asia Pacific - Equine Healthcare Market Value (US$ Mn) Forecast, by Country, 2020 to 2035

Table 29: Asia Pacific - Equine Healthcare Market Value (US$ Mn) Forecast, by Product Type, 2020 to 2035

Table 30: Asia Pacific - Equine Healthcare Market Value (US$ Mn) Forecast, By Therapeutics, 2020 to 2035

Table 31: Asia Pacific - Equine Healthcare Market Value (US$ Mn) Forecast, By Drugs, 2020 to 2035

Table 32: Asia Pacific - Equine Healthcare Market Value (US$ Mn) Forecast, By Vaccine, 2020 to 2035

Table 33: Asia Pacific - Equine Healthcare Market Value (US$ Mn) Forecast, By Supplemental Feed Additives, 2020 to 2035

Table 34: Asia Pacific - Equine Healthcare Market Value (US$ Mn) Forecast, By Diagnostics, 2020 to 2035

Table 35: Asia Pacific - Equine Healthcare Market Value (US$ Mn) Forecast, by Indication, 2020 to 2035

Table 36: Asia Pacific - Equine Healthcare Market Value (US$ Mn) Forecast, By End-user, 2020 to 2035

Table 37: Latin America - Equine Healthcare Market Value (US$ Mn) Forecast, by Country, 2020 to 2035

Table 38: Latin America - Equine Healthcare Market Value (US$ Mn) Forecast, by Product Type, 2020 to 2035

Table 39: Latin America - Equine Healthcare Market Value (US$ Mn) Forecast, By Therapeutics, 2020 to 2035

Table 40: Latin America - Equine Healthcare Market Value (US$ Mn) Forecast, By Drugs, 2020 to 2035

Table 41: Latin America - Equine Healthcare Market Value (US$ Mn) Forecast, By Vaccine, 2020 to 2035

Table 42: Latin America - Equine Healthcare Market Value (US$ Mn) Forecast, By Supplemental Feed Additives, 2020 to 2035

Table 43: Latin America - Equine Healthcare Market Value (US$ Mn) Forecast, By Diagnostics, 2020 to 2035

Table 44: Latin America - Equine Healthcare Market Value (US$ Mn) Forecast, by Indication, 2020 to 2035

Table 45: Latin America - Equine Healthcare Market Value (US$ Mn) Forecast, By End-user, 2020 to 2035

Table 46: Middle East & Africa - Equine Healthcare Market Value (US$ Mn) Forecast, by Country, 2020 to 2035

Table 47: Middle East & Africa - Equine Healthcare Market Value (US$ Mn) Forecast, by Product Type, 2020 to 2035

Table 48: Middle East & Africa - Equine Healthcare Market Value (US$ Mn) Forecast, By Therapeutics, 2020 to 2035

Table 49: Middle East & Africa - Equine Healthcare Market Value (US$ Mn) Forecast, By Drugs, 2020 to 2035

Table 50: Middle East & Africa - Equine Healthcare Market Value (US$ Mn) Forecast, By Vaccine, 2020 to 2035

Table 51: Middle East & Africa - Equine Healthcare Market Value (US$ Mn) Forecast, By Supplemental Feed Additives, 2020 to 2035

Table 52: Middle East & Africa - Equine Healthcare Market Value (US$ Mn) Forecast, By Diagnostics, 2020 to 2035

Table 53: Middle East & Africa - Equine Healthcare Market Value (US$ Mn) Forecast, by Indication, 2020 to 2035

Table 54: Middle East & Africa - Equine Healthcare Market Value (US$ Mn) Forecast, By End-user, 2020 to 2035

List of Figures

Figure 01: Global Equine Healthcare Market Value Share Analysis, By Product Type, 2024 and 2035

Figure 02: Global Equine Healthcare Market Attractiveness Analysis, By Product Type, 2025 to 2035

Figure 03: Global Equine Healthcare Market Revenue (US$ Mn), by Therapeutics, 2020 to 2035

Figure 04: Global Equine Healthcare Market Revenue (US$ Mn), by Diagnostics, 2020 to 2035

Figure 05: Global Equine Healthcare Market Value Share Analysis, By Indication, 2024 and 2035

Figure 06: Global Equine Healthcare Market Attractiveness Analysis, By Indication, 2025 to 2035

Figure 07: Global Equine Healthcare Market Revenue (US$ Mn), by Equine Influenza, 2020 to 2035

Figure 08: Global Equine Healthcare Market Revenue (US$ Mn), by Equine Herpes virus (EHV), 2020 to 2035

Figure 09: Global Equine Healthcare Market Revenue (US$ Mn), by Equine Encephalomyelitis, 2020 to 2035

Figure 10: Global Equine Healthcare Market Revenue (US$ Mn), by West Nile Virus, 2020 to 2035

Figure 11: Global Equine Healthcare Market Revenue (US$ Mn), by Equine Rabies, 2020 to 2035

Figure 12: Global Equine Healthcare Market Revenue (US$ Mn), by Potomac Horse Fever, 2020 to 2035

Figure 13: Global Equine Healthcare Market Revenue (US$ Mn), by Osteoarthritis, 2020 to 2035

Figure 14: Global Equine Healthcare Market Revenue (US$ Mn), by Tetanus, 2020 to 2035

Figure 15: Global Equine Healthcare Market Revenue (US$ Mn), by Others, 2020 to 2035

Figure 16: Global Equine Healthcare Market Value Share Analysis, By End-user, 2024 and 2035

Figure 17: Global Equine Healthcare Market Attractiveness Analysis, By End-user, 2025 to 2035

Figure 18: Global Equine Healthcare Market Revenue (US$ Mn), by Veterinary Hospitals, 2020 to 2035

Figure 19: Global Equine Healthcare Market Revenue (US$ Mn), by Equine Clinics, 2020 to 2035

Figure 20: Global Equine Healthcare Market Revenue (US$ Mn), by Equestrian Facilities, 2020 to 2035

Figure 21: Global Equine Healthcare Market Revenue (US$ Mn), by Others, 2020 to 2035

Figure 22: Global Equine Healthcare Market Value Share Analysis, By Region, 2024 and 2035

Figure 23: Global Equine Healthcare Market Attractiveness Analysis, By Region, 2025 to 2035

Figure 24: North America - Equine Healthcare Market Value (US$ Mn) Forecast, 2020 to 2035

Figure 25: North America - Equine Healthcare Market Value Share Analysis, by Country, 2024 and 2035

Figure 26: North America - Equine Healthcare Market Attractiveness Analysis, by Country, 2025 to 2035

Figure 27: North America Equine Healthcare Market Value Share Analysis, By Product Type, 2024 and 2035

Figure 28: North America Equine Healthcare Market Attractiveness Analysis, By Product Type, 2025 to 2035

Figure 29: North America - Equine Healthcare Market Value Share Analysis, By Indication, 2024 and 2035

Figure 30: North America - Equine Healthcare Market Attractiveness Analysis, By Indication, 2025 to 2035

Figure 31: North America - Equine Healthcare Market Value Share Analysis, By End-user, 2024 and 2035

Figure 32: North America - Equine Healthcare Market Attractiveness Analysis, By End-user, 2025 to 2035

Figure 33: Europe - Equine Healthcare Market Value (US$ Mn) Forecast, 2020 to 2035

Figure 34: Europe - Equine Healthcare Market Value Share Analysis, by Country, 2024 and 2035

Figure 35: Europe - Equine Healthcare Market Attractiveness Analysis, by Country, 2025 to 2035

Figure 36: Europe Equine Healthcare Market Value Share Analysis, By Product Type, 2024 and 2035

Figure 37: Europe Equine Healthcare Market Attractiveness Analysis, By Product Type, 2025 to 2035

Figure 38: Europe - Equine Healthcare Market Value Share Analysis, By Indication, 2024 and 2035

Figure 39: Europe - Equine Healthcare Market Attractiveness Analysis, By Indication, 2025 to 2035

Figure 40: Europe - Equine Healthcare Market Value Share Analysis, By End-user, 2024 and 2035

Figure 41: Europe - Equine Healthcare Market Attractiveness Analysis, By End-user, 2025 to 2035

Figure 42: Asia Pacific - Equine Healthcare Market Value (US$ Mn) Forecast, 2020 to 2035

Figure 43: Asia Pacific - Equine Healthcare Market Value Share Analysis, by Country, 2024 and 2035

Figure 44: Asia Pacific - Equine Healthcare Market Attractiveness Analysis, by Country, 2025 to 2035

Figure 45: Asia Pacific Equine Healthcare Market Value Share Analysis, By Product Type, 2024 and 2035

Figure 46: Asia Pacific Equine Healthcare Market Attractiveness Analysis, By Product Type, 2025 to 2035

Figure 47: Asia Pacific - Equine Healthcare Market Value Share Analysis, By Indication, 2024 and 2035

Figure 48: Asia Pacific - Equine Healthcare Market Attractiveness Analysis, By Indication, 2025 to 2035

Figure 49: Asia Pacific - Equine Healthcare Market Value Share Analysis, By End-user, 2024 and 2035

Figure 50: Asia Pacific - Equine Healthcare Market Attractiveness Analysis, By End-user, 2025 to 2035

Figure 51: Latin America - Equine Healthcare Market Value (US$ Mn) Forecast, 2020 to 2035

Figure 52: Latin America - Equine Healthcare Market Value Share Analysis, by Country, 2024 and 2035

Figure 53: Latin America - Equine Healthcare Market Attractiveness Analysis, by Country, 2025 to 2035

Figure 54: Latin America Equine Healthcare Market Value Share Analysis, By Product Type, 2024 and 2035

Figure 55: Latin America Equine Healthcare Market Attractiveness Analysis, By Product Type, 2025 to 2035

Figure 56: Latin America - Equine Healthcare Market Value Share Analysis, By Indication, 2024 and 2035

Figure 57: Latin America - Equine Healthcare Market Attractiveness Analysis, By Indication, 2025 to 2035

Figure 58: Latin America - Equine Healthcare Market Value Share Analysis, By End-user, 2024 and 2035

Figure 59: Latin America - Equine Healthcare Market Attractiveness Analysis, By End-user, 2025 to 2035

Figure 60: Middle East & Africa - Equine Healthcare Market Value (US$ Mn) Forecast, 2020 to 2035

Figure 61: Middle East & Africa - Equine Healthcare Market Value Share Analysis, by Country, 2024 and 2035

Figure 62: Middle East & Africa - Equine Healthcare Market Attractiveness Analysis, by Country, 2025 to 2035

Figure 63: Middle East & Africa Equine Healthcare Market Value Share Analysis, By Product Type, 2024 and 2035

Figure 64: Middle East & Africa Equine Healthcare Market Attractiveness Analysis, By Product Type, 2025 to 2035

Figure 65: Middle East & Africa - Equine Healthcare Market Value Share Analysis, By Indication, 2024 and 2035

Figure 66: Middle East & Africa - Equine Healthcare Market Attractiveness Analysis, By Indication, 2025 to 2035

Figure 67: Middle East & Africa - Equine Healthcare Market Value Share Analysis, By End-user, 2024 and 2035

Figure 68: Middle East & Africa - Equine Healthcare Market Attractiveness Analysis, By End-user, 2025 to 2035

Copyright © Transparency Market Research, Inc. All Rights reserved